Tocilizumab Designated as Breakthrough Therapy for GCA Michele B. Kaufman, PharmD, BCGP | October 26, 2016To speed the development of tocilizumab to treat giant cell arteritis (GCA), the FDA designated it as a breakthrough therapy earlier this month…